血小板凝集デバイスの世界市場、2024-2031年

世界の血小板凝集デバイス市場は、予測期間（2024-2031年）に17.9％の大幅なCAGRで成長すると予測されます。市場成長の背景には、血小板スクリーニングプログラムに対する需要の高まりや技術の改良に加え、受容性と認知度の向上があります。BCMによると、2023年9月、細胞治療、再生医療、標的ドラッグデリバリーシステムにおけるp-EV、HPL、同種血小板の臨床応用における最新の進歩が本分析で詳細に検討されています。

心臓病、脳卒中、関連疾患の有病率の増加

心血管障害および末梢血管障害の有病率の上昇により、診断および治療アプローチを開発するための継続的な研究が求められており、血小板凝集デバイスは不可欠な要素となっています。英国心臓財団（British Heart Foundation）によると、2024年1月、心臓および循環器疾患は引き続き世界の健康上の重大な問題であり、世界の約13人に1人が罹患しています。2019年には、2億9,000万人の女性と2億6,000万人の男性がこれらの疾患を患っていると推定されています。これらの疾患の有病率は、世界的に年々着実に増加しています。さらに、心臓病、末梢動脈疾患、脳卒中、心房細動は、最も一般的な心血管疾患のひとつであり、総称して数百万人の個人に影響を及ぼしています。悲劇的なことに、心臓および循環器疾患は依然として世界の死因の第1位であり、2021年には死亡者数の約3人に1人、すなわち2,050万人を占めます。

病院が最大セグメントと予測

エンドユーザー別に見ると、血小板凝集デバイス市場は病院、診断研究所、研究・学術機関、その他に細分化されます。なかでも、病院のサブセグメントが市場の最大シェアを占めると予想されます。このセグメントの成長を支える主な要因としては、病院における正確な診断と患者ケアに対する需要の増加が挙げられます。

インピーダンス血小板凝集計は製品別で大きな市場シェアを占める

インピーダンスベースの検出技術を利用した全血サンプル中の血小板凝集測定の開発が進んでいます。国立衛生研究所（gov.）によると、2019年10月、本研究では、複数の血小板活性化因子を利用し、マルチプレート装置を用いたインピーダンス凝集計を利用して血小板凝集を測定しました。全血検体を用いたインピーダンス凝集測定は、忍耐を要し、専門施設で利用可能な古典的なボルナ凝集測定とは対照的に、手術中に迅速に結果を得ることを可能にしました。

地域別展望

世界の血小板凝集デバイス市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。

アジア太平洋地域が最も速いCAGRを示す

その結果、臨床用途の需要が高まっており、各社はこの需要の高まりに対応するため、手術用の新しく革新的な製品を発売しています。例えば、2022年2月、FuturaSurgicarePvt.Ltd.は、Hemostaxというブランドで止血製品を発売しました。婦人科、腫瘍、心臓血管、一般手術など様々な手術に適しています。

北米が主要市場シェアを占める

北米は、センサーの感度、自動化、データ分析など、血小板凝集デバイス技術の進歩の重要性により、全地域の中で大きなシェアを占めています。

Anesthesiology誌によると、2023年9月、この研究には合計50人の患者が含まれ、35.0％が冠動脈バイパス術、52.0％が弁膜症手術、12.0％が大動脈基部手術を受けた。1サイクルあたりの赤血球回収率の中央値は86.1％で、治療後のヘマトクリットは41.8％でした。ヘパリン除去率は98.9％、遊離ヘモグロビン除去率は94.6％でした。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• At F. Hoffmann-La Roche Ltd.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Bio/Data Corp.
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Greiner Bio-One International GmbH
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 血小板凝集デバイスの世界市場：製品別
  • 光学式血小板凝集計
  • インピーダンス血小板凝集計
  • 光血小板凝集計
  • 全血血小板凝集デバイス
  • 血小板凝集試薬
  • その他（多電極凝集計（MEA）装置、光透過凝集計）
• 血小板凝集デバイスの世界市場：エンドユーザー別
  • 病院
  • 診断研究所
  • 研究・学術機関
  • その他（血液銀行、製薬・バイオテクノロジー企業）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• AggreDyne, Inc.
• Chrono-Log Corp.
• Drucker Diagnostics
• Grifols, S.A.
• Haemonetics
• HeamochromDiagnostica GmbH
• Hetzner Online GmbH
• Matis Medical, Inc.
• Medtronic Pvt. Ltd.
• Perlong Medical Equipment Co., Ltd.
• SENTINEL CH. SpA
• Siemens Healthineers co.
• Sienco, Inc.
• Sysmex Corp.
• Tem Group
• Werfen, S.A.

LIST OF TABLES

• 1.GLOBAL PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 2.GLOBAL OPTICAL PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3.GLOBAL IMPEDANCE PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4.GLOBAL PHOTOMETRIC PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 5.GLOBAL WHOLE BLOOD PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 6.GLOBAL PLATELET AGGREGATION REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 7.GLOBAL OTHERS PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8.GLOBAL PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 9.GLOBAL PLATELET AGGREGATION DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 10.GLOBAL PLATELET AGGREGATION DEVICES FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 11.GLOBAL PLATELET AGGREGATION DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 12.GLOBAL PLATELET AGGREGATION DEVICES FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 13.GLOBAL PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 14.NORTH AMERICAN PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 15.NORTH AMERICAN PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 16.NORTH AMERICAN PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 17.EUROPEAN PLATELET AGGREGATION DEVICESMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 18.EUROPEAN PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 19.EUROPEAN PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 20.ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 21.ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 22.ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
• 23.REST OF THE WORLD PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 24.REST OF THE WORLD PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2023-2031 ($ MILLION)
• 25.REST OF THE WORLD PLATELET AGGREGATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1.GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE BY PRODUCT, 2023 VS 2031 (%)
• 2.GLOBAL OPTICAL PLATELET AGGREGATION DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 3.GLOBAL IMPEDANCE PLATELET AGGREGATION DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 4.GLOBAL PHOTOMETRIC PLATELET AGGREGATION DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 5.GLOBAL WHOLE BLOOD PLATELET AGGREGATION DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 6.GLOBAL PLATELET AGGREGATION REAGENTS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 7.GLOBAL OTHERS PLATELET AGGREGATION DEVICES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 8.GLOBAL PLATELET AGGREGATION DEVICES MARKET SHARE BY END-USER, 2023 VS 2031 (%)
• 9.GLOBAL PLATELET AGGREGATION DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 10.GLOBAL PLATELET AGGREGATION DEVICES FOR DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 11.GLOBAL PLATELET AGGREGATION DEVICES FOR RESEARCH AND ACADEMIC INSTITUTES MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 12.GLOBAL PLATELET AGGREGATION DEVICES FOR OTHERS MARKET SHARE BY REGION, 2023 VS 2031 (%)
• 13.GLOBAL PLATELET AGGREGATION DEVICES MARKETSHARE BY REGION, 2023 VS 2031 (%)
• 14.US PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 15.CANADA PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 16.UK PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 17.FRANCE PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 18.GERMANY PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 19.ITALY PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 20.SPAIN PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 21.REST OF EUROPE PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 22.INDIA PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 23.CHINA PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 24.JAPAN PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 25.SOUTH KOREA PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 26.REST OF ASIA-PACIFIC PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 27.LATIN AMERICA PLATELET AGGREGATION DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 28.MIDDLE EAST AND AFRICA PLATELET AGGREGATION DEVICESMARKET SIZE, 2023-2031 ($ MILLION)

Global Platelet Aggregation Devices Market Size, Share & Trends Analysis Report by Product (Optical Platelet Aggregometers, Impedance Platelet Aggregometers, Photometric Platelet Aggregometers, Whole Blood Platelet Aggregation Devices, Platelet Aggregation Reagents, and Others), and by End-User (Hospitals, Diagnostic Laboratories, Research and Academic Institutes, and Others) Forecast Period (2024-2031)

Global platelet aggregation devices market is anticipated to grow at a significant CAGR of 17.9% during the forecast period (2024-2031). The market's growth is attributed to growing acceptability and awareness, in addition to rising demand for platelet screening programs and technology improvements. According to the BCM, in September 2023,the latest advancements in the clinical application of p-EVs, HPLs, and allogeneic platelets in cell therapy, regenerative medicine, and targeted drug delivery systems are examined in depth in this analysis.

Market Dynamics

Increasing prevalence of heart disease, strokes, and related disorders

The rising prevalence of cardiovascular and peripheral vascular disorders calls for ongoing research to develop diagnostic and treatment approaches, with platelet aggregation devices providing an essential component. According to theBritish Heart Foundation, in January 2024Heart and circulatory diseases continue to be a significant global health concern, affecting approximately 1 in 13 people globally. In 2019, there were an estimated 290 million women and 260 million men living with these conditions. The prevalence of these diseases has been steadily increasing over the years, with the global number of cases. Additionally, heart disease, peripheral arterial disease, stroke, and atrial fibrillation are among the most common cardiovascular conditions, collectively impacting millions of individuals. Tragically, heart and circulatory diseases remain the leading cause of death globally, accounting for approximately 1 in 3 fatalities, or 20.5 million fatalities in 2021.

Market Segmentation

Our in-depth analysis of the global platelet aggregation devicesmarket includes the following segments by product, end user:

• Based on product, the market is sub-segmented into optical platelet aggregometers, impedance platelet aggregometers, photometric platelet aggregometers, whole blood platelet aggregation devices, platelet aggregation reagents, and others.
• Based on end-user, the market is bifurcated into hospitals, diagnostic laboratories, research and academic institutes, and others.

Hospital is Projected to Emerge as the Largest Segment

Based on the end user, the platelet aggregation devices market is sub-segmented into hospitals, diagnostic laboratories, research and academic institutes, and others. Among these, the hospital sub-segment is expected to hold the largest share of the market. The primary factor supporting the segment's growth includes the increasing demand for accurate diagnoses and patient care in hospitals.

Impedance Platelet Aggregometers Holds Considerable Market Share Based on Product

The increasing development in the measurement of platelet aggregation in whole-blood samples utilizing impedance-based detection techniques. According to the National Institute of Health (gov.), in October 2019, in the present study, several platelet activators were utilized to measure platelet aggregation utilizing impedance aggregometry using the multiplate equipment. Impedance aggregometry using whole-blood samples allowed for rapidly results during surgery, in contrast to classical Bornaggregometry, that demands patience and is accessible in specialized facilities.

Regional Outlook

The global platelet aggregation devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

Asia-Pacific to Exhibit Fastest CAGR

The growing demand for clinical uses corresponds with the common surgical techniques performed by surgeons in India.As a result there is growing demand for clinical applications and accordingly companies are launching new and innovative products for surgeries to meet this growing demands.For instance, inFebruary 2022FuturaSurgicarePvt. Ltd. has introduced Hemostatic products under the brand Hemostax, an absorbable hemostat designed to aid surgeons in controlling bleeding. It is suitable for various surgeries, including gynecologic, oncologic, cardiovascular, and general procedures.

North America Holds Major Market Share

Among all the regions, North America holds a significant share owing to the he significance of advancements in platelet aggregation device technology, including sensor sensitivity, automation, and data analytics.

According to the Anesthesiology, in September 2023,the study included a total of 50 patients, with 35.0% undergoing isolated coronary artery bypass graft, 52.0% valve surgery, and 12.0% aortic root surgery. The median red blood cell recovery per cycle was 86.1%, with a posttreatment hematocrit of 41.8%. The device showed high removal ratios for heparin and free hemoglobin, at 98.9% and 94.6% respectively.

Market Players Outlook

The major companies serving the global platelet aggregation devices market includeAggreDyne, Inc.Medtronic Pvt. Ltd.,SiemensHealthineers co.,Sysmex Corp. Werfen, S.A. and others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in January 2023 Precision BioLogic Inc., launched new CRYOcheck Chromogenic Factor IX assay. The CRYOcheck Chromogenic Factor IX is a FDA-cleared assay used in clinical labs to identify factor IX deficiency in human plasma, aiding in hemophilia B management.

The Report Covers:

• Market value data analysis of 2023and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global platelet aggregation devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.At F. Hoffmann-La Roche Ltd.
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.Bio/Data Corp.
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.Greiner Bio-One International GmbH
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Platelet Aggregation Devices Market by Product
  • 4.1.1.Optical Platelet Aggregometers
  • 4.1.2.Impedance Platelet Aggregometers
  • 4.1.3.Photometric Platelet Aggregometers
  • 4.1.4.Whole Blood Platelet Aggregation Devices
  • 4.1.5.Platelet Aggregation Reagents
  • 4.1.6.Others(Multiple Electrode Aggregometry (MEA) Devices, and Light Transmission Aggregometers)
• 4.2.Global Platelet Aggregation Devices Market by End-User
  • 4.2.1.Hospitals
  • 4.2.2.Diagnostic Laboratories
  • 4.2.3.Research and Academic Institutes
  • 4.2.4.Others (Blood Banks and Pharmaceutical &Biotechnology Companies)

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
  • 5.3.5.Rest of Asia-Pacific
• 5.4.Rest of the World

6.Company Profiles

• 6.1.AggreDyne, Inc.
• 6.2.Chrono-Log Corp.
• 6.3.Drucker Diagnostics
• 6.4.Grifols, S.A.
• 6.5.Haemonetics
• 6.6.HeamochromDiagnostica GmbH
• 6.7.Hetzner Online GmbH
• 6.8.Matis Medical, Inc.
• 6.9.Medtronic Pvt. Ltd.
• 6.10.Perlong Medical Equipment Co., Ltd.
• 6.11.SENTINEL CH. SpA
• 6.12.Siemens Healthineers co.
• 6.13.Sienco, Inc.
• 6.14.Sysmex Corp.
• 6.15.Tem Group
• 6.16.Werfen, S.A.